PEXAB.ST

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Medical - Specialties

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
PEXAB.STPexa AB	$0.25	-0.40%	$10M	—
AMNI.STAmniotics AB (publ)	$0.01	+5.88%	$15M	—
BONZUN.STBonzun AB (publ)	$0.01	+0.00%	$7M	—
CYXO.STCyxone AB (publ)	$0.02	+0.00%	$7M	—
HEMC.STHemcheck Sweden AB (publ)	$0.23	+26.11%	$9M	—
IDOGEN.STIdogen AB (publ)	$0.12	-2.82%	$13M	—
L2S.STLearning 2 Sleep L2S AB (publ)	$0.02	+2.50%	$12M	—

Source: Financial Modeling Prep · peers by sector/industry

Pexa AB

Pexa AB specializes in developing and commercializing innovative technologies within the realm of respiratory medicine. The firm provides lung researchers with a straightforward, non-invasive technique to collect microscopic particles that serve as potential biomarkers for conditions affecting the small airways. Established in 2010 by Anna-Carin Olin, Pexa AB is based in Gothenburg, Sweden.

www.pexa.se

HQ: SE

Held by traders on TradeandTell

No one on the platform currently holds PEXAB.ST.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in PEXAB.ST as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded PEXAB.ST yet.